Lake, MD 9:50 – 9:55 AM Discussion 9:55 – 10:15 AM Surviving and

Lake, MD 9:50 – 9:55 AM Discussion 9:55 – 10:15 AM Surviving and Thriving with Value and Excellence From an Administrative Perspective Jennifer

Milton, RN, MSN 10:15 – 10:20 AM Discussion 10:20 -10:30 AM Break Session II: Successes and Challenges in Sustaining Excellence in Private Health Care Systems 10:30 – 10:50 AM Perspectives From A Surgical Program Director William C. Chapman, MD 10:50 – 10:55 AM Discussion 10:55 – 11:15 AM Perspectives From A Medical Program Director-Private Sector James F. Trotter, MD 11:15 – 11:20 AM Discussion 11:20 – 11:40 FDA-approved Drug Library AM Surviving and Thriving with Value and Excellence Karen Hess, RN, MS, MBA, ACNP 11:40 – 11:45 AM Discussion 11:45 AM – Noon Panel Discussion Meet-the-Professor Luncheon Saturday, November 2 12:15 -1:15 PM Refer to your luncheon ticket for meeting

room location. MTP-1 Use of Statins in Patients with Liver Disease Curtis K. Argo, MD and Naga P. Chalasani, MD MTP-2 Safe Prescribing in Liver Disease James H. Lewis, MD and Timothy J. Davern, MD MTP-3 Herbs and Natural Remedies in Patients with Liver Disease Victor J. Navarro, MD and Leonard B. Seeff, MD MTP-4 HCV: Treat Now or Wait Paul J. Pockros, MD and Christoph Sarrazin, MD MTP-5 HCV: Side Effects of New selleck products Antiviral Agents John F. Reinus, M.D. and Reem H. Ghalib, MD MTP-6 Hepatitis C Management in the Liver Transplant Candidate Catherine T. Frenette, MD and Marina Berenguer, MD MTP-7 The Hepatitis C Drug Pipeline Douglas T. Dieterich, MD and Raymond T. Chung, MD MTP-8 Optimal Management of Hepatic Encephalopathy Norman Gitlin, MD and Kevin D. Mullen, MD MTP-9 Viral Hepatitis and HIV Infection Norbert Brau, MD and Maribel Rodriguez-Torres, MD MTP-10 Viral Hepatitis in Patients Undergoing

Heart, Kidney and Bone Marrow Transplants Michael P. Curry, MD and Maya Gambarin-Gelwan, MD MTP-11 HCC: How to Screen Roniel Cabrera, MD and Jose Franco, MD MTP-12 NAFLD: Who to Biopsy Neeral L. Shah, MD and Nizar N. Zein, MD MTP-13 OLT: Improving Long-term Outcomes Francisco A. Durazo, MD and Jacqueline G. O’Leary, MD MTP-14 Endoscopy Issues in Patients with End-stage Liver Disease Vijay Shah, MD and Bruce A. Luxon, MD, PhD MTP-15 Alcoholic Hepatitis: selleck inhibitor What Should I do? Philippe Mathurin, MD, PhD and Timothy R. Morgan, MD Poster Session I Saturday, November 2 2: 00 – 7: 30 PM Hall E Refer to page 92A for Poster Presentations Exhibit Hall Opening and Reception Saturday, November 2 5: 00 – 7: 30 PM Hall D Transplant Surgery Workshop Saturday, November 2 3:30 – 7:00 PM Room 146A Management of Rare Liver Tumors COURSE DIRECTORS: Sasan Roayaie, MD Kenneth D. Chavin, MD, PhD 3.5 CME Credits The program will provide the audience with an evidence based review of the current diagnostic and treatment strategies for less commonly encountered liver tumors.

Related posts:

  1. This brief discussion of the relationship between training effec
  2. Discussion The conserved position of helix 12 in NR function su
  3. Discussion After many years of debate, there is now ample proof t
  4. Paclitaxel induces apoptosis down-regulates surviving in human breast most cancers MCF-seven cells
  5. The western-southern perimeter of the village borders on Lake Vic
This entry was posted in Antibody. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>